Tue, Sep 16, 2014, 5:29 AM EDT - U.S. Markets open in 4 hrs 1 mins


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • calaggie71 calaggie71 Sep 4, 2013 2:25 PM Flag



    Astex Pharmaceuticals Inc. (ASTX:US), the maker of an experimental leukemia therapy, jumped the most in 17 years after a report that Japanese drugmaker Otsuka Holdings Co. (4578) has decided to buy the biotechnology company for an estimated $900 million (90 billion yen).

    Astex rose 29 percent to $8.59 at 1:44 p.m. New York time, giving the Dublin, California-based company a market value of $817 million. Astex earlier climbed as much as 41 percent, its largest intraday increase since 1996.

    Japan’s Nikkei newspaper reported today that Tokyo-based Otsuka will buy Astex to increase its stable of cancer drugs. Astex reported on Aug. 28 that its experimental treatment SGI-110 had positive results in a mid-stage clinical trial of myeloid leukemia patients.

    Timothy Enns, a spokesman for Astex, didn’t immediately repond to an e-mail or answer a phone call seeking comment on the report.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT